This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignee: Cornell University. Active years: 2009-2013.
Company Filing History:
Years Active: 2009-2013
Title: Innovations of Rosandra N Kaplan in Cancer Treatment
Introduction
Rosandra N Kaplan is a notable inventor based in New York, NY (US). She has made significant contributions to the field of cancer treatment through her innovative research and patented inventions. With a total of 2 patents, her work focuses on the use of vascular endothelial growth factor receptor 1+ cells in treating and monitoring cancer.
Latest Patents
Kaplan's latest patents include a method for inhibiting tumor formation in cancer patients at sites remote from previous tumor formations. This invention also addresses the prevention of metastases. The methods involve administering an inhibitor of vascular endothelial growth factor receptor 1 bone marrow-derived cells to the patient. This approach is designed to either inhibit tumor formation or prevent metastases effectively. Additionally, candidate compounds can be screened based on their ability to bind to these specific cells. Monitoring metastases can be achieved by evaluating patient samples for the detection and quantification of vascular endothelial growth factor receptor 1 bone marrow-derived cells, comparing current levels to prior measurements.
Career Highlights
Kaplan is associated with the Cornell Research Foundation Inc., where she continues her research and development in cancer therapies. Her work has garnered attention for its potential impact on cancer treatment protocols.
Collaborations
Some of her notable coworkers include David C Lyden and Rebecca D Riba, who contribute to the collaborative efforts in advancing cancer research.
Conclusion
Rosandra N Kaplan's innovative work in cancer treatment exemplifies the importance of research and development in the medical field. Her patents reflect a commitment to improving patient outcomes and advancing therapeutic strategies.